Nasdaq

change direction new plan alter arrows move reprioritize
Favicon Fierce Pharma

Cybin alters state to become Helus Pharma for Nasdaq trip

Cybin is shedding its old identity, evolving into Helus Pharma as part of changes that will see its shares move to a different stock exchange.
Nick Paul Taylor Dec 19, 2025 10:30am
Medline truck

Medline makes Nasdaq debut, raising $6.26B in year's largest IPO

Dec 17, 2025 11:11am
IPO initial public offering Wall Street

Lumexa Imaging IPO tallies $462.5M, doubling original target

Dec 15, 2025 9:40am
Medline Industries Northfield Illinois headquarters

Medline sets terms for massive $5.37B Nasdaq IPO

Dec 9, 2025 11:19am
blood test vials

Freenome to go public in $330M SPAC deal

Dec 5, 2025 10:35am
A doctor is pointing at an x-ray of a human torso The background is white and in sharp contrast with the x-ray film

Lumexa Imaging eyes IPO expected to raise $200M

Nov 19, 2025 12:28pm